海洋分枝杆菌MMAR_4110抗原DNA疫苗接种抑制成年斑马鱼潜伏分枝杆菌感染再激活
本研究以成年斑马鱼海洋分枝杆菌感染模型模拟人结核潜伏感染再激活,通过mRNA测序筛选再激活相关基因,并评估7个候选基因作为DNA疫苗的抗原潜力。结果显示MMAR_0444、MMAR_0514、MMAR_0552、MMAR_0641、MMAR_1093、MMAR_4110和MMAR_4524在再激活时上调,其中4种MMAR_4110抗原能阻止潜伏感染再激活。
要点
- 斑马鱼海洋分枝杆菌模型可模拟人结核潜伏感染再激活过程。
- mRNA测序鉴定7个再激活相关基因,MMAR_4110抗原可抑制再激活。
- 该模型为结核疫苗和药物开发提供临床前候选靶点。
核心结论
- MMAR_4110抗原DNA疫苗可抑制成年斑马鱼潜伏海洋分枝杆菌感染的再激活。
研究设计与样本
- 研究采用成年斑马鱼海洋分枝杆菌感染模型,用Wayne模型制备缺氧培养物并再曝气以体外模拟再激活。
- 对指数生长期、厌氧培养及再曝气后2和12小时的细菌进行mRNA测序,筛选7个再激活相关基因并评估其DNA疫苗抗原潜力。
- 组间细菌计数差异采用Mann-Whitney检验评估。
主要发现
- mRNA测序显示MMAR_0444、MMAR_0514、MMAR_0552、MMAR_0641、MMAR_1093、MMAR_4110和MMAR_4524在再激活时较休眠和指数生长期细菌上调。
- 4种不同的MMAR_4110抗原能阻止成年斑马鱼潜伏分枝杆菌感染的再激活。
临床怎么用
- MMAR_4110抗原可作为进一步研发抗分枝杆菌疫苗和药物的候选靶点。
- 斑马鱼模型可用于结核潜伏感染再激活的临床前疫苗评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis is a major challenge for health care, as options for its treatment and prevention are limited. Therefore, novel approaches, such as DNA vaccination, to both prevent primary infections and the reactivation of latent infections need to be developed. A Mycobacterium marinum infection in adult zebrafish (Danio rerio) recapitulates features of the human Mycobacterium tuberculosis infection, providing a convenient preclinical animal model for studying tuberculosis. METHODS: Hypoxic M. marinum cultures were produced with the Wayne model, and further reaerated to replicate the in vivo reactivation in vitro. Expression levels of M. marinum genes were studied with mRNA sequencing from exponentially growing bacteria, anaerobic cultures and at 2 and 12 h after reaeration. Seven reactivation-associated genes were selected for further studies, where their antigen potentiality as DNA-vaccines to prevent reactivation of a latent mycobacterial infection was investigated in the adult zebrafish model. The Mann-Whitney test was used to evaluate differences in bacterial counts between the groups. RESULTS: The mRNA sequencing data showed that, seven M. marinum genes, MMAR_0444, MMAR_0514, MMAR_0552, MMAR_0641, MMAR_1093, MMAR_4110 and MMAR_4524, were upregulated during reactivation when compared to both dormant and logarithmic growing bacteria. Four different MMAR_4110 antigens prevented the reactivation of a latent mycobacterial infection in the adult zebrafish. CONCLUSION: This study provides novel information about reactivation-related M. marinum genes. One of the antigens, MMAR_4110, inhibited the reactivation of a latent M. marinum infection in zebrafish, implicating that the characterized genes could be potential targets for further vaccine and drug development against mycobacterial diseases.
引用
- Niskanen M, Myllymäki H, Rämet M, et al. DNA vaccination with the Mycobacterium marinum MMAR_4110 antigen inhibits reactivation of a latent mycobacterial infection in the adult Zebrafish. Vaccine. 2020. PMID: 32624250. doi:10.1016/j.vaccine.2020.06.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。